PRICE T ROWE ASSOCIATES INC /MD/
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$729,757
+$334,576 QoQ
Shares Held
54,869
+29.3% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 158 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,554,498,511 across 303 Biotechnology names. FDMT ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in FDMT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $729,757 | 54,869 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $395,181 | 42,447 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $290,602 | 38,747 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $391,293 | 45,028 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $131,066 | 35,328 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $85,685 | 26,528 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $147,861 | 26,546 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $330,083 | 30,535 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $630,623 | 30,044 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $763,110 | 23,952 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $457,794 | 22,596 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $273,567 | 21,490 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $341,884 | 18,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $315,969 | 18,381 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $385,987 | 17,379 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $145,588 | 18,108 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $110,214 | 15,790 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $171,990 | 11,375 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $234,209 | 10,675 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $12,135,381 | 279,746 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,245,453 | 343,678 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||